Rafarma Pharmaceuticals Inc (RAFA)
Rafarma Pharmaceuticals Inc. is a common stock listing on OTC Markets tied to a healthcare company focused on pharmaceuticals. The company develops and sells drugs in Russia, including generic antibiotics, cephalosporin-based products, specialty pharmaceuticals, and anti-cancer medicines. Its product forms include injections, ampoules, pediatric suspensions, tablets, and capsules, and its portfolio also includes treatments for accidental wounds, inflammatory eye diseases, and immunological disorders. Rafarma has also announced a collaboration with PlantEXT Ltd. to research and manufacture medical cannabis suppositories for patients with inflammatory bowel disease. The company was previously known as Johnston Acquisition Corp. and adopted its current name in October 2012. It is based in Sandy, Utah, with manufacturing and distribution operations in Russia, and as of October 19, 2020, it has operated as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-RAFA
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
1.975 M
|
